Allena Pharmaceuticals Inc (NASDAQ:ALNA)
| 1.71 Delayed Data As of 3:59pm ET |  -0.025 / -1.45%Today’s Change | 0.53 Today|||52-Week Range 3.39 | +33.20% Year-to-Date |
Latest ALNA News | Press Releases
No recent news for Allena Pharmaceuticals Inc.
Today’s Trading
| Previous close | 1.73 |
| Today’s open | 1.75 |
| Day’s range | 1.68 - 1.75 |
| Volume | 11,520 |
| Average volume (3 months) | 1,874,616 |
| Market cap | $80.5M |
Data as of 3:59pm ET, 03/02/2021
Growth & Valuation
| Earnings growth (last year) | -24.18% |
| Earnings growth (this year) | +56.81% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.42 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PPBTPurple Biotech Ltd | -0.30 | -6.34% |
| ARPOAerpio Pharmaceutica... | -0.01 | -0.85% |
| DAREDare Bioscience Inc | -0.10 | -5.05% |
| ATXIAvenue Therapeutics ... | +0.96 | +18.43% |
Data as of 3:59pm ET, 03/02/2021
Financials
| Next reporting date | March 30, 2021 |
| EPS forecast (this quarter) | -$0.19 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$47.3M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Newton, Massachusetts |
Forecasts
